MDA has awarded $300,000 to Children's National Medical Center to maintain a valuable research mouse testing facility

posted on March 7, 2012 - 6:00am
The Muscular Dystrophy Association has given a $300,000 grant to the Center for Genetic Medicine Research (CGMR) at Children’s National Medical Center in Washington, D.C., to continue standardized and reliable preclinical studies of neuromuscular diseases.

Treatment with the protein prolactin improved motor function and enhanced survival time in mice with a disease resembling severe SMA

posted on August 8, 2011 - 3:02pm
The administration of a protein called prolactin has been shown to slow weight loss, improve motor function and increase life span by approximately 70 percent in mice with a disease resembling a severe form of spinal muscular atrophy (SMA). Prolactin is a hormone whose primary function is to promote milk production in women who are breastfeeding.
posted on September 1, 2008 - 10:07am
QUEST Vol. 15, No. 5
Real progress is being made in supplying functional dystrophin genes to treat Duchenne muscular dystrophy (DMD), a disease in which mutated dystrophin genes keep this critical protein from being produced in muscle fibers.
posted on March 1, 2006 - 9:49am
QUEST Vol. 13, No. 2
Team IDs Consequences of FSH MD Mutation First mouse model could be used to test therapies
posted on July 1, 2005 - 2:53pm
QUEST Vol. 12, No. 4
In 1984, two years before mutations in the X-chromosome gene for the muscle protein now known as dystrophin were identified as the cause of Duchenne MD, researchers at the University of California at Berkeley and an agricultural center in Scotland announced they’d found an X-linked muscular dystrophy in mice. (Doctors had long known that DMD was a genetic disease and that, because of its...